FDA Inspection 1166863 — Adventist Healthcare IRB
The FDA completed an inspection of Adventist Healthcare IRB on March 29, 2022 in Gaithersburg, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 29, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Gaithersburg, MD (United States)
Additional Details
IRB